Elewski B, Menter A, Crowley J, Tyring S, Zhao Y, Lowry S, Rozzo S, Mendelsohn A, Parno J, Gordon K. Sustained and Improved Efficacy of Tildrakizumab from Week 28 to Week 52 in Treating Moderate-to-Severe Plaque Psoriasis. J of Skin [Internet]. 2018 Feb. 23 [cited 2024 Jul. 23];2(S1):S22. Available from: https://jofskin.org/33014/index.php/skin/article/view/305